/AI10h ago

Andrej Karpathy and Kim Isenberg highlight a five-week surge of breakthroughs across gene editing, oncology, and diagnostic AI

Updates include Eli Lilly's retatrutide and Mayo Clinic radiology tools.

--0--
Original posts
Chubby♨️#1496
Quote posts
Chubby♨️#1496
Reposts
Andrej Karpathy#1
Original post
Chubby♨️@kimmonismus#1496inAI

We are witnessing a revolution in medicine driven by AI. Dreams are turning into reality right before our eyes.

Obesity is becoming a problem of the past. Eli Lilly's triple agonist, retatrutide, melts fat away, and with it the many downstream consequences of obesity. Since the Industrial Revolution, obesity has grown into one of the most serious problems of modern civilization - and now it is being solved. Literally.

Cancers that were once untreatable are becoming treatable thanks to new medicines: melanoma, pancreatic cancer, and many more. And that's before mentioning the other benefits of GLP-1 agonists, such as their anti-inflammatory effects.

We are entering what Demis Hassabis calls the "golden age of science." Anyone willing to open their eyes can see it. Science is unfolding in all its potential right in front of us.

I couldn't be happier, or more grateful - grateful to witness this.

9:42 AM · Jun 2, 2026 · 15.4K Views
Sentiment
Sentiment building, check back later.
Cluster Engagement
-
Views
-
Comments
-
Reposts
-
Bookmarks
Expand data
Posts from X
Most Activity
Most ActivityTimeline
VIEWS4.2KBOOKMARKS2LIKES10
Chubby♨️@kimmonismus

source 1:

10hViews 4.2KLikes 10Bookmarks 2
RETWEETS1.7K
Derek Thompson@DKThomp

This has quietly been a miracle month in medicine.

In the last 5 weeks we’ve got news on:

- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels - RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life - small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol - Mayo’s AI-assisted radiology showing vastly improved cancer detection - this new therapy for metastatic solid tumors

This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.

2dViews 2.2MLikes 10.3KBookmarks 4.1K
REPLIES1
Chubby♨️@kimmonismus

Source 3:

Derek Thompson@DKThomp

This has quietly been a miracle month in medicine.

In the last 5 weeks we’ve got news on:

- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels - RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life - small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol - Mayo’s AI-assisted radiology showing vastly improved cancer detection - this new therapy for metastatic solid tumors

This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.

10hViews 302Likes 2Bookmarks 0